NEXIMMUNE INC. DL-,0001NEXIMMUNE INC. DL-,0001NEXIMMUNE INC. DL-,0001

NEXIMMUNE INC. DL-,0001

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪544.64 K‬EUR
−228.053EUR
‪−29.30 M‬EUR
0.00EUR
‪1.18 M‬
Beta (1Y)
0.73

About NEXIMMUNE INC. DL-,0001


CEO
Craig R. Jalbert
Headquarters
Gaithersburg
Founded
2011
FIGI
BBG00Z8XT8H4
NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke on June 7, 2011 and is headquartered in Gaithersburg, MD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BER exchange NEXIMMUNE INC. DL-,0001 stocks are traded under the ticker 7370.
Yes, you can track NEXIMMUNE INC. DL-,0001 financials in yearly and quarterly reports right on TradingView.
NEXIMMUNE INC. DL-,0001 is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
7370 net income for the last quarter is ‪−2.17 M‬ EUR, while the quarter before that showed ‪−2.85 M‬ EUR of net income which accounts for 23.83% change. Track more NEXIMMUNE INC. DL-,0001 financial stats to get the full picture.
No, 7370 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 4, 2024, the company has 6.00 employees. See our rating of the largest employees — is NEXIMMUNE INC. DL-,0001 on this list?
Like other stocks, 7370 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXIMMUNE INC. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.